Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function

NCT02134288 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT02134288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02134288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized Trial of Belatacept Switch in Renal Transplant Recipients With Delayed Graft Function
Lead sponsor
Ohio State University
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2014
Completion date
January 18, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed graft function